Novavax reported $0 in Stock for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Adamas Pharmaceuticals ADMS:US 8.68M 892K
Adma Biologics ADMA:US $ 114.12M 14.42M
Biocryst Pharmaceuticals BCRX:US $ 13.66M 3.82M
Dynavax Technologies DVAX:US $ 67.3M 19.15M
GlaxoSmithKline GSK:LN 6244M 86M
Mannkind MNKD:US $ 7.48M 0M
Novavax NVAX:US $ 0 0
Peregrine Pharmaceuticals PPHM:US $ 20.31M 5.07M